近视的药物治疗  

Drug therapy for myopia

作　　者：刘凌(综述)[1] 张美霞(审校)[1] LIU Ling;ZHANG Meixia(Department of Ophthalmology,West China Hospital of Sichuan University,Chengdu 610041,Sichuan,China)

机构地区：[1]四川大学华西医院眼科,四川成都610041

出　　处：《山东大学耳鼻喉眼学报》2021年第4期123-128,共6页Journal of Otolaryngology and Ophthalmology of Shandong University

摘　　要：近视是最常见的屈光不正,若不行矫正,可造成视觉损伤,影响个人生活质量,造成社会经济负担,成为严重的公共卫生问题。随着近视患病率不断上升,控制近视度数增长,保护眼健康,成为全球关注热点。目前治疗近视的方法包括药物、配镜、手术等。近年来药物治疗近视取得了一定的进展,本文对发现能控制近视的药物,包括毒蕈碱受体拮抗剂、烟碱型受体拮抗剂、血管活性肠肽等治疗近视的机制及研究进展进行综述。Myopia is the most common refractive error.Uncorrected refractive error,causing visual impairment,has become an important question of commonality sanitation,owing to affecting the quality of life of individuals and the weightily economy burden.With the prevalence of myopia increasing,controlling myopia progression and protecting eye health have gradually become the hot issue of global concern.And its current treatments include drugs,glasses,and surgery.In recent years,progress has been made in the treatment of myopia.This article focuses on the progress of research on drugs for controlling myopia,including muscarinic receptor antagonists,nicotinic receptor antagonists,and vasoactive intestinal peptides,and their mechanisms of action.

关 键 词：近视 药物治疗 阿托品 毒蕈碱受体拮抗剂 眼压 

分 类 号：R778[医药卫生—眼科]